Emergency Nursing Management of Hyperkalemia in Dialysis Patients: Evidence-Based Interventions for Critical Electrolyte Imbalance
Keywords:
Hyperkalemia, Dialysis patients, Emergency nursing, Electrolyte imbalance, Cardiac arrhythmiaAbstract
Background: Hyperkalemia is a life-threatening electrolyte imbalance commonly seen in dialysis patients due to impaired renal potassium excretion, missed dialysis sessions, dietary factors, and medication effects, leading to severe cardiac complications and increased risk of sudden cardiac arrest if untreated. Aims: To review pathophysiology, risk factors, clinical features, and evidence-based emergency nursing interventions for hyperkalemia in dialysis patients. Methods: This review was conducted using published peer-reviewed articles, clinical guidelines, and nursing literature focusing on hyperkalemia in dialysis patients. Databases including Google Scholar and PubMed were explored to identify relevant studies. Key themes such as pathophysiology, risk factors, clinical manifestations, emergency management, and nursing interventions were analyzed. Evidence from recent studies was synthesized to present updated clinical practices and nursing strategies for effective emergency management of hyperkalemia. Results: Findings indicate that hyperkalemia in dialysis patients is primarily caused by reduced renal potassium excretion, inadequate dialysis, dietary potassium intake, and drug-related factors. Clinically, it presents with neuromuscular weakness, gastrointestinal symptoms, and life-threatening cardiac manifestations such as arrhythmias and ECG changes. Evidence-based nursing interventions include immediate cardiac monitoring, calcium gluconate administration, insulin-glucose therapy, and preparation for hemodialysis. Potassium redistribution therapies provide temporary stabilization, while dialysis offers definitive correction. Early recognition and rapid nursing response significantly reduce mortality and improve patient outcomes in emergency settings. Conclusion: Early nursing intervention, continuous monitoring, and timely dialysis are essential to prevent complications and reduce mortality in hyperkalemia among dialysis patients.
References
K. Goia-Nishide, L. Coregliano-Ring, and É. B. Rangel, “Hyperkalemia in Diabetes Mellitus Setting,” Diseases, vol. 10, no. 2, Art. no. 20, 2022, doi: 10.3390/diseases10020020.
N. L. Larivée, J. B. Michaud, K. M. More, J.-A. Wilson, and K. K. Tennankore, “Hyperkalemia: Prevalence, Predictors and Emerging Treatments,” Cardiology and Therapy, vol. 12, no. 1, pp. 35–63, 2023, doi: 10.1007/s40119-022-00289-z.
S. Yamada and M. Inaba, “Potassium Metabolism and Management in Patients with CKD,” Nutrients, vol. 13, no. 6, Art. no. 1751, 2021, doi: 10.3390/nu13061751.
D. Bem et al., “The Effect of Hyperkalemia and Long Inter-dialytic Interval on Morbidity and Mortality in Patients Receiving Hemodialysis: A Systematic Review,” Renal Failure, vol. 43, no. 1, pp. 241–254, 2021, doi: 10.1080/0886022X.2020.1871012.
S. Shibata and S. Uchida, “Hyperkalemia in Patients Undergoing Hemodialysis: Its Pathophysiology and Management,” Therapeutic Apheresis and Dialysis, vol. 26, no. 1, pp. 3–14, 2022, doi: 10.1111/1744-9987.13721.
P. Esposito et al., “New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease,” Journal of Clinical Medicine, vol. 9, no. 8, Art. no. 2337, 2020, doi: 10.3390/jcm9082337.
A. Rakisheva, M. Marketou, A. Klimenko, T. Troyanova-Shchutskaia, and P. Vardas, “Hyperkalemia in Heart Failure: Foe or Friend?,” Clinical Cardiology, vol. 43, no. 7, pp. 666–675, 2020, doi: 10.1002/clc.23392.
B. C. Drumheller et al., “Severe Bradycardia from Severe Hyperkalemia: Patient Characteristics, Outcomes and Factors Associated with Hemodynamic Support,” The American Journal of Emergency Medicine, vol. 55, pp. 117–125, 2022, doi: 10.1016/j.ajem.2022.03.007.
L. Lemoine, Q. Le Bastard, E. Batard, and E. Montassier, “An Evidence-Based Narrative Review of the Emergency Department Management of Acute Hyperkalemia,” The Journal of Emergency Medicine, vol. 60, no. 5, pp. 599–606, 2021, doi: 10.1016/j.jemermed.2020.11.028.
M. Suárez-Rivera, L. M. Satlin, and M. Bonilla-Félix, “Potassium Disorders: Evaluation and Management,” in Pediatric Nephrology. Cham, Switzerland: Springer International Publishing, 2022, pp. 1123–1143, doi: 10.1007/978-3-030-52719-8_114.
S. Bansal and P. E. Pergola, “Current Management of Hyperkalemia in Patients on Dialysis,” Kidney International Reports, vol. 5, no. 6, pp. 779–789, 2020, doi: 10.1016/j.ekir.2020.02.1028.
K. I. Greenberg and M. J. Choi, “Hemodialysis Emergencies: Core Curriculum 2021,” American Journal of Kidney Diseases, vol. 77, no. 5, pp. 796–809, 2021, doi: 10.1053/j.ajkd.2020.11.024.
M. Pirklbauer, “Hemodialysis Treatment in Patients with Severe Electrolyte Disorders: Management of Hyperkalemia and Hyponatremia,” Hemodialysis International, vol. 24, no. 3, pp. 282–289, 2020, doi: 10.1111/hdi.12845.
S. Mazzaferro et al., “Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression,” Journal of Clinical Medicine, vol. 10, no. 5, Art. no. 958, 2021, doi: 10.3390/jcm10050958.
M.-T. Yan, C.-T. Chao, and S.-H. Lin, “Chronic Kidney Disease: Strategies to Retard Progression,” International Journal of Molecular Sciences, vol. 22, no. 18, Art. no. 10084, 2021, doi: 10.3390/ijms221810084.
B. Maliszewski et al., “Quality Improvement in the Emergency Department: A Project to Reduce Door-to-Electrocardiography Times for Patients Presenting With Chest Pain,” Journal of Emergency Nursing, vol. 46, no. 4, pp. 497–504.e2, 2020, doi: 10.1016/j.jen.2020.03.004.
A. Sarnowski, R. M. Gama, A. Dawson, H. Mason, and D. Banerjee, “Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management,” International Journal of Nephrology and Renovascular Disease, vol. 15, pp. 215–228, 2022, doi: 10.2147/IJNRD.S326464.
L. Yao et al., “Effects of Different Potassium-Lowering Regimens on Acute Hyperkalemia in Hemodialysis Patients: A Real-World, Retrospective Study,” Journal of Translational Medicine, vol. 20, no. 1, Art. no. 333, 2022, doi: 10.1186/s12967-022-03530-4.
S. Borrelli et al., “Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers,” International Journal of Molecular Sciences, vol. 23, no. 12, Art. no. 6378, 2022, doi: 10.3390/ijms23126378.
H. Arif, “Complications of Chronic Kidney Disease: Electrolyte and Acid-Base Disorders,” in Approaches to Chronic Kidney Disease. Cham, Switzerland: Springer International Publishing, 2022, pp. 211–233, doi: 10.1007/978-3-030-83082-3_12.
J. M. Valdivielso et al., “Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies,” Drugs, vol. 81, no. 13, pp. 1467–1489, 2021, doi: 10.1007/s40265-021-01555-5.
F. Palmieri et al., “Monitoring Blood Potassium Concentration in Hemodialysis Patients by Quantifying T-Wave Morphology Dynamics,” Scientific Reports, vol. 11, no. 1, Art. no. 3883, 2021, doi: 10.1038/s41598-021-82935-5.
L. H. Larsen, W. J. Z’Graggen, H. Bostock, S. V. Tan, N. H. Buus, and H. Tankisi, “The Role of Potassium in Muscle Membrane Dysfunction in End-Stage Renal Disease,” Clinical Neurophysiology, vol. 132, no. 12, pp. 3125–3135, 2021, doi: 10.1016/j.clinph.2021.09.012.
Z. Rafique et al., “Hyperkalemia and Electrocardiogram Manifestations in End-Stage Renal Disease,” International Journal of Environmental Research and Public Health, vol. 19, no. 23, Art. no. 16140, 2022, doi: 10.3390/ijerph192316140.
S. Bianchi and G. M. Rossi, “Predicting Hyperkalemia in Patients with Acute Kidney Injury: Time for a Change of Weaponry,” Internal and Emergency Medicine, vol. 15, no. 3, pp. 371–372, 2020, doi: 10.1007/s11739-019-02245-7.
C. Bures et al., “Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism—New Thresholds for Urgent Perioperative Dialysis,” Journal of Clinical Medicine, vol. 11, no. 2, Art. no. 409, 2022, doi: 10.3390/jcm11020409.
F. Assadi, M. Mazaheri, and E. M. Rad, “Electrocardiography Is Unreliable to Detect Potential Lethal Hyperkalemia in Patients with Non-dialysis Chronic Kidney Disease,” Pediatric Cardiology, vol. 43, no. 5, pp. 1064–1070, 2022, doi: 10.1007/s00246-022-02826-y.
L. A. Raffee et al., “Clinical and Electrocardiogram Presentations of Patients with High Serum Potassium Concentrations Within Emergency Settings: A Prospective Study,” International Journal of Emergency Medicine, vol. 15, no. 1, Art. no. 23, 2022, doi: 10.1186/s12245-022-00422-8.
X. Jin et al., “hsa_circNFXL1_009 Modulates Apoptosis, Proliferation, Migration, and Potassium Channel Activation in Pulmonary Hypertension,” Molecular Therapy Nucleic Acids, vol. 23, pp. 1007–1019, 2021, doi: 10.1016/j.omtn.2020.09.029.
B. F. Palmer, “Potassium Binders for Hyperkalemia in Chronic Kidney Disease—Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis,” Mayo Clinic Proceedings, vol. 95, no. 2, pp. 339–354, 2020, doi: 10.1016/j.mayocp.2019.05.019.
F. A. Goncalves et al., “Hypokalemia and Hyperkalemia in Patients on Peritoneal Dialysis: Incidence and Associated Factors,” International Urology and Nephrology, vol. 52, no. 2, pp. 393–398, 2020, doi: 10.1007/s11255-020-02385-2.
N. Teymouri et al., “ECG Frequency Changes in Potassium Disorders: A Narrative Review,” American Journal of Cardiovascular Disease, vol. 12, no. 3, pp. 112–124, 2022.
P. N. Chandrasekaran, A. Pandey, and P. S. Idiculla, “Neuromuscular Emergencies in the Neuroscience Intensive Care Unit,” in Neuromuscular Urgencies and Emergencies. Cham, Switzerland: Springer International Publishing, 2020, pp. 95–129, doi: 10.1007/978-3-030-53145-4_5.
N. Mammadova et al., “A Patient with Severe Metformin-Associated Lactic Acidosis Complicated by Acute Coronary Syndrome: A Case Report,” BMC Nephrology, vol. 23, no. 1, Art. no. 174, 2022, doi: 10.1186/s12882-022-02781-z.
G. Regolisti, U. Maggiore, P. Greco, C. Maccari, E. Parenti, F. Di Mario, V. Pistolesi, S. Morabito, and E. Fiaccadori, “Electrocardiographic T Wave Alterations and Prediction of Hyperkalemia in Patients with Acute Kidney Injury,” Internal and Emergency Medicine, vol. 15, no. 3, pp. 463–472, 2020, doi: 10.1007/s11739-019-02217-x.
S. Fishbane et al., “Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting,” Journal of Renal Nutrition, vol. 32, no. 4, pp. e1–e14, 2022, doi: 10.1053/j.jrn.2021.06.003.
Z. Rafique, F. Peacock, T. Armstead, J. J. Bischof, J. Hudson, M. R. Weir, and J. Neuenschwander, “Hyperkalemia Management in the Emergency Department: An Expert Panel Consensus,” JACEP Open, vol. 2, no. 5, Art. no. e12572, 2021, doi: 10.1002/emp2.12572.
A. P. Maggioni, “Maintaining the Balance Between Benefits and Risks: The Example of Hyperkalemia in Patients with Heart Failure,” Revista Portuguesa de Cardiologia (English Edition), vol. 39, no. 9, pp. 543–544, 2020, doi: 10.1016/j.repce.2020.11.019.
C. Lin et al., “Point-of-Care Artificial Intelligence-Enabled ECG for Dyskalemia: A Retrospective Cohort Analysis for Accuracy and Outcome Prediction,” NPJ Digital Medicine, vol. 5, no. 1, Art. no. 8, 2022, doi: 10.1038/s41746-021-00550-0.
N. Kose and F. Bilgin, “Successful Treatment of a Patient with Cardiac Arrest Due to Hyperkalemia by Prolonged Cardiopulmonary Resuscitation Along with Hemodialysis: A Case Report and Review of the Literature,” Medicina, vol. 57, no. 8, Art. no. 810, 2021, doi: 10.3390/medicina57080810.
J. D. Farkas, B. Long, A. Koyfman, and K. Menson, “BRASH Syndrome: Bradycardia, Renal Failure, AV Blockade, Shock, and Hyperkalemia,” The Journal of Emergency Medicine, vol. 59, no. 2, pp. 216–223, 2020, doi: 10.1016/j.jemermed.2020.05.001.
E. N. M. de Rooij et al., “Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study,” Kidney Medicine, vol. 4, no. 1, Art. no. 100379, 2022, doi: 10.1016/j.xkme.2021.08.013.
A. Cupisti et al., “Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients,” Toxins, vol. 13, no. 4, Art. no. 289, 2021, doi: 10.3390/toxins13040289.
K. E. Nollet, A. M. Ngoma, and H. Ohto, “Transfusion-Associated Graft-Versus-Host Disease, Transfusion-Associated Hyperkalemia, and Potassium Filtration: Advancing Safety and Sufficiency of the Blood Supply,” Transfusion and Apheresis Science, vol. 61, no. 2, Art. no. 103408, 2022, doi: 10.1016/j.transci.2022.103408.
M. Pietribiasi, J. Waniewski, W. Załuska, A. Wójcik-Załuska, and J. K. Leypoldt, “Comparison of Two Single-Solute Models of Potassium Kinetics During Hemodialysis,” Biocybernetics and Biomedical Engineering, vol. 40, no. 3, pp. 938–949, 2020, doi: 10.1016/j.bbe.2020.04.001.
D. Tsiagka et al., “Prevalence, Recurrence and Seasonal Variation of Hyperkalemia Among Patients on Hemodialysis,” International Urology and Nephrology, vol. 54, no. 9, pp. 2327–2334, 2022, doi: 10.1007/s11255-022-03142-3.
A. B. Elliott, K. M. M. Soliman, and M. E. Ullian, “Hyperkalemia in Chronic Peritoneal Dialysis Patients,” Renal Failure, vol. 44, no. 1, pp. 217–223, 2022, doi: 10.1080/0886022X.2022.2032151.
V. Calabrese et al., “Correlation Between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease,” Journal of Clinical Medicine, vol. 11, no. 1, Art. no. 244, 2022, doi: 10.3390/jcm11010244.
F. Caravaca-Fontán et al., “Renal Potassium Management in Chronic Kidney Disease: Differences Between Patients with or Without Hyperkalemia,” Nefrología (English Edition), vol. 40, no. 2, pp. 152–159, 2020, doi: 10.1016/j.nefroe.2020.03.006.
S. Kohsaka, S. Okami, E. Kanda, N. Kashihara, and T. Yajima, “Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study,” Mayo Clinic Proceedings: Innovations, Quality & Outcomes, vol. 5, no. 2, pp. 274–285, 2021, doi: 10.1016/j.mayocpiqo.2020.10.001.
K. Kalantar-Zadeh et al., “Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney Disease,” Nutrients, vol. 12, no. 7, Art. no. 1931, 2020, doi: 10.3390/nu12071931.
K. Picard, M. Griffiths, D. R. Mager, and C. Richard, “Handouts for Low-Potassium Diets Disproportionately Restrict Fruits and Vegetables,” Journal of Renal Nutrition, vol. 31, no. 2, pp. 210–214, 2021, doi: 10.1053/j.jrn.2020.07.001.
C. Ramakrishnan et al., “Healthcare Professionals’ Perspectives on Facilitators of and Barriers to CKD Management in Primary Care: A Qualitative Study in Singapore Clinics,” BMC Health Services Research, vol. 22, no. 1, Art. no. 560, 2022, doi: 10.1186/s12913-022-07949-9.
E. Pintado-Outumuro et al., “Exploring the Factors Influencing Evidence-Based Approaches to Advanced Chronic Kidney Disease: A Qualitative Study Involving Nurses and Physicians,” BMC Primary Care, vol. 25, no. 1, Art. no. 177, 2024, doi: 10.1186/s12875-024-02418-0.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Central Asian Journal of Medical and Natural Science

This work is licensed under a Creative Commons Attribution 4.0 International License.
